 Prevention cisplatin-induced emesis double-blind multicenter crossover study ondansetron ondansetron dexamethasone Ondansetron OND new receptor antagonist complete protection emesis/nausea cisplatin CDDP patients dexamethasone DEX OND increases antiemetic efficacy double-blind crossover study antiemetic activity OND OND DEX chemotherapy-naive patients women men CDDP chemotherapy doses equal study Eighty-nine patients cycles following results complete protection emesis/nausea patients OND OND DEX end study patients treatment preference chose OND DEX OND significant difference Side effects mild different treatments OND DEX efficacious OND patients CDDP-induced emesis nausea